drugset / Trial / NCT00845481

A Plaque Test Comparing the Anti-psoriatic Effect of Marketed Products for Topical Use for Psoriasis Vulgaris

NCT00845481

Phase 2 Completed 24 enrolled LEO Pharma
RandomizedSingle-groupSingle-blindOther

Summary

The purpose of the study is to compare the anti-psoriatic effect of marketed products with Daivobet® ointment in a plaque test

Timeline

Start
2009-01
Primary completion
2009-03
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Betnovat Unknown Topical
Subject Daivobet Unknown Topical
Subject Dermovat Unknown Topical
Subject Diprosalic Unknown Topical
Subject Mometasone furoate Other / unclassified Topical

Indications